Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Dermira vets license back candidates from Eli Lilly to launch their own upstart
Endpoints
Thu, 01/7/21 - 11:35 am
Tags:
Demira, Eli Lilly, Evommune
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Fierce Pharma
Tue, 01/5/21 - 10:52 pm
Tags:
Eli Lilly, Amgen, migraines, Allergan, Novartis, Biohaven, Teva Pharmaceutical
Eli Lilly's transpacific bosom buddy Terns bags late-round funding to drive NASH hopefuls through the clinic
Endpoints
Tue, 01/5/21 - 10:03 am
Tags:
NASH, Terns Pharmaceuticals, Eli Lilly
Eli Lilly to buy New York drugmaker for up to $1B
Beckers Hospital Review
Thu, 12/31/20 - 11:59 am
Tags:
Eli Lilly, Prevail Therapeutics, M&A, neurodegenerative disease
GlaxoSmithKline, Vir look to succeed where Lilly failed with NIH antibody study in hospitalized Covid-19 patients
Endpoints
Thu, 12/17/20 - 06:25 pm
Tags:
GSK, Vir Biotechnology, Eli Lilly, antibodies, NIH, COVID-19, clinical trials
Lilly and Regeneron COVID-19 antibodies are available all over the U.S. Why aren't they getting to more patients?
Fierce Pharma
Thu, 12/17/20 - 06:19 pm
Tags:
FDA, Eli Lilly, Regeneron, antibodies, COVID-19
13 drugmakers contracted by Operation Warp Speed in 2020
Beckers Hospital Review
Wed, 12/16/20 - 10:36 pm
Tags:
HHS, Operation Warp Speed, COVID-19, vaccines, Cytiva, Eli Lilly, AstraZeneca, Emergent BioSolutions, Fujifilm, JNJ, Moderna Therapeutics, Pfizer, BioNTech, Novavax, Regeneron, Sanofi, GSK
Lilly's Tirzepatide Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes
Drugs.com
Tue, 12/15/20 - 08:24 pm
Tags:
Eli Lilly, tirzepatide, clinical trials, type 2 diabetes, diabetes
Lilly to acquire gene therapy specialist, Prevail Therapeutics, in a deal worth US$1.04bn
Biopharma Reporter
Tue, 12/15/20 - 10:57 am
Tags:
Eli Lilly, Prevail Therapeutics, M&A
Lilly's tirzepatide drives deep drops in blood sugar and body weight in diabetes phase 3
Fierce Biotech
Wed, 12/9/20 - 10:46 am
Tags:
Eli Lilly, tirzepatide, type 2 diabetes, clinical trials
Physicians express skepticism about Lilly arthritis drug OK'd as COVID-19 treatment
Beckers Hospital Review
Tue, 12/8/20 - 10:33 am
Tags:
Eli Lilly, olumiant, COVID-19, physicians
AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation
Fierce Biotech
Mon, 12/7/20 - 10:37 am
Tags:
AbCellera, Eli Lilly, R&D, Canada, COVID-19, antibodies, IPOs
#ASH20: Loxo and Eli Lilly show off PhI/II data for their BTK inhibitor in mantle cell lymphoma
Endpoints
Sat, 12/5/20 - 11:28 pm
Tags:
ASH2020, Eli Lilly, clinical trials, LOXO-305, Loxo Oncology, mantle cell lymphoma, non-Hodgkin lymphoma
[video+transcript]Here's Why Biotech Deals Are All the Rage Right Now
Motley Fool
Sat, 12/5/20 - 11:24 pm
Tags:
biotech, M&A, Biogen, SAGE Therapeutics, Eli Lilly, Precision Biosciences, Merck, OncoImmune
Eli Lilly announces 650,000 additional doses of bamlanivimab purchased by US government to treat Covid-19
Pharmaceutical Business Review
Thu, 12/3/20 - 10:51 am
Tags:
Eli Lilly, antibodies, bamlanivimab, COVID-19, government contract
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
Pharmaforum
Wed, 12/2/20 - 10:33 am
Tags:
Roche, Blueprint Medicines, Gavreto, thyroid cancer, Retevmo, Eli Lilly
Could Eli Lilly and Precision BioSciences Make Breakthroughs for DMD?
BioSpace
Fri, 11/20/20 - 11:09 am
Tags:
Eli Lilly, Precision Biosciences, Duchenne Muscular Dystrophy
Eli Lilly picks up another Covid-19 EUA as regulators wave through its Olumiant plus remdesivir combo
Endpoints
Thu, 11/19/20 - 11:09 pm
Tags:
Eli Lilly, FDA, COVID-19, Emergency Use Authorization, olumiant, remdesivir
Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as IPO rumors heat up
Endpoints
Thu, 11/19/20 - 10:21 am
Tags:
AbCellera, Eli Lilly, Regeneron, Trianni, monoclonal antibodies
How Effective Will Lilly’s Bamlanivimab be in the Battle Against COVID-19?
BioSpace
Mon, 11/16/20 - 10:08 am
Tags:
Eli Lilly, bamlanivimab, LY-CoV555, COVID-19, antibodies

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.